Drug – bio-affecting and body treating compositions – Radionuclide or intended radionuclide containing; adjuvant... – In an organic compound
Reexamination Certificate
2006-03-21
2006-03-21
Jones, Dameron L. (Department: 1618)
Drug, bio-affecting and body treating compositions
Radionuclide or intended radionuclide containing; adjuvant...
In an organic compound
C424S001110, C424S001490, C424S001650, C424S009100, C424S009200
Reexamination Certificate
active
07014838
ABSTRACT:
The present invention relates to the use of proteins that are differentially expressed in primary brain tumor tissues, as compared to normal brain tissues, as biomolecular targets for brain tumor treatment therapies. Specifically, the present invention relates to the use of immunotherapeutic and immunoimaging agents, which specifically bind to one or more of the identified brain tumor protein targets. The present invention also provides compounds and pharmaceutically acceptable compositions for administration in the methods of the invention. Nucleic acid probes specific for the spliced mRNA encoding these variants and affinity reagents specific for the novel proteins are also provided.
REFERENCES:
Accession No. AF071202.
Accession No. AF152331.
Accession No. AY007162.
Accession No. BC000214.
Accession No. BC000726.
Accession No. BC004892.
Accession No. D13866.
Accession No. NM—004720.
Accession No. XM—004372.
Accession No. XM—006607.
Accession No. XM—007289.
Accession No. XM—017039.
Accession No. XM—071910.
Accession No. XM—008971.
Accession No. XM—011168.
Mariani et al., Glioma cell Motility is Associated With Reduced Transription of Proapoptotic and Proliferatio Genes: A CNDA Microarray Analysis, Journal of Neuro-Oncology, (2001), 53: 161-176.
Markert et al., Differential Gene Expression Profiling in human Brain Tumors, Physiol. Genomics, (2001), 5: 21-33.
Kroes et al., The Identification of Novel Therapeutic Targets for the Treatment of Malignant Brain Tumors, Cancer Letters, (2000), 156: 191-198.
Reis et al., Short Communication Genetic Profile of Gliosarcomas, American Journal of Pathology, (2003), 156: (2) 245-432.
Yano et al., Differential Expression of β-Catenin in Human Glioblastoma Multiforme and Normal Brain Tissue, Neurological Research, (2000), 22: 650-656.
Chin Daniel J.
Foehr Erik
Gonzalez-Zulueta Mirella
Mueller Sabine
AGY Therapeutics, Inc.
Bozicevic Field & Francis LLP
Jones Dameron L.
Sherwood Pamela J.
Taylor Rebecca D.
LandOfFree
Use of biomolecular targets in the treatment and... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Use of biomolecular targets in the treatment and..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Use of biomolecular targets in the treatment and... will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-3527875